Search This Blog

Thursday, May 7, 2026

Ironwood Q1 profit of $40.8 m on $106.5 m revenue, guides 2026 revenue to $450-$475 m

 

Ironwood Pharmaceuticals posts Q1 profit of $40.8 million on $106.5 million revenue, guides 2026 revenue to $450-$475 million

  • Q1 2026 net income reported as $41 million, with LINZESS U.S. sales up 97% YoY
  • Ironwood Pharmaceuticals affirms its 2026 guidance after releasing Q1 2026 financial results

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.